Immix Biopharma
Price & Volume
Stats
See more52W Range | $1.94-$12.14 |
Market Cap | $626.4M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.92 |
News
See moreYahoo Finance • 5 days ago
Straight Out Of A Soap Opera: Biotech Exec Arrested After 21 Years On The Run
Yahoo Finance • 6 days ago
IMMX ALERT: Immix Biopharma Investigated for Securities Fraud Violations by Block & Leviton; Investors Should Contact the Firm
Yahoo Finance • 2 months ago
Immix Biopharma Prices $150 Million Underwritten Offering To Advance NXC-201 Program
Yahoo Finance • 2 months ago
Immix Biopharma Soars On 95% Complete Response Rate In Interim Data From NEXICART-2 Trial Of NXC-201
About
CEO | Dr. Ilya Rachman M.B.A., M.D., Ph.D. |
CFO | Mr. Gabriel Morris B.A. |
Address | 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |